Logo image of ZENV

ZENVIA INC - A (ZENV) Stock Fundamental Analysis

NASDAQ:ZENV - Nasdaq - KYG9889V1014 - Common Stock - Currency: USD

1.64  +0.01 (+0.61%)

After market: 1.7 +0.06 (+3.66%)

Fundamental Rating

3

Taking everything into account, ZENV scores 3 out of 10 in our fundamental rating. ZENV was compared to 283 industry peers in the Software industry. ZENV has a bad profitability rating. Also its financial health evaluation is rather negative. ZENV has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

ZENV had negative earnings in the past year.
In the past year ZENV had a positive cash flow from operations.
ZENV had negative earnings in each of the past 5 years.
Of the past 5 years ZENV 4 years had a positive operating cash flow.
ZENV Yearly Net Income VS EBIT VS OCF VS FCFZENV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

ZENV has a Return On Assets (-5.42%) which is in line with its industry peers.
ZENV has a Return On Equity (-12.08%) which is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 0.86%, ZENV is in the better half of the industry, outperforming 63.96% of the companies in the same industry.
Industry RankSector Rank
ROA -5.42%
ROE -12.08%
ROIC 0.86%
ROA(3y)-8.63%
ROA(5y)-6.61%
ROE(3y)-17.47%
ROE(5y)-14.93%
ROIC(3y)N/A
ROIC(5y)N/A
ZENV Yearly ROA, ROE, ROICZENV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

ZENV's Operating Margin of 1.03% is fine compared to the rest of the industry. ZENV outperforms 62.54% of its industry peers.
In the last couple of years the Operating Margin of ZENV has declined.
ZENV's Gross Margin of 26.42% is on the low side compared to the rest of the industry. ZENV is outperformed by 79.15% of its industry peers.
ZENV's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.03%
PM (TTM) N/A
GM 26.42%
OM growth 3YN/A
OM growth 5Y-41.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.3%
GM growth 5Y3.13%
ZENV Yearly Profit, Operating, Gross MarginsZENV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ZENV is destroying value.
ZENV has more shares outstanding than it did 1 year ago.
ZENV has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ZENV has a worse debt to assets ratio.
ZENV Yearly Shares OutstandingZENV Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ZENV Yearly Total Debt VS Total AssetsZENV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

ZENV has an Altman-Z score of 0.43. This is a bad value and indicates that ZENV is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.43, ZENV is doing worse than 68.20% of the companies in the same industry.
ZENV has a debt to FCF ratio of 1.51. This is a very positive value and a sign of high solvency as it would only need 1.51 years to pay back of all of its debts.
ZENV has a better Debt to FCF ratio (1.51) than 69.26% of its industry peers.
ZENV has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
ZENV's Debt to Equity ratio of 0.04 is in line compared to the rest of the industry. ZENV outperforms 57.60% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 1.51
Altman-Z 0.43
ROIC/WACC0.05
WACC18.69%
ZENV Yearly LT Debt VS Equity VS FCFZENV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 0.44 indicates that ZENV may have some problems paying its short term obligations.
ZENV has a worse Current ratio (0.44) than 91.87% of its industry peers.
ZENV has a Quick Ratio of 0.44. This is a bad value and indicates that ZENV is not financially healthy enough and could expect problems in meeting its short term obligations.
ZENV has a worse Quick ratio (0.44) than 91.17% of its industry peers.
Industry RankSector Rank
Current Ratio 0.44
Quick Ratio 0.44
ZENV Yearly Current Assets VS Current LiabilitesZENV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

5

3. Growth

3.1 Past

ZENV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.83%, which is quite impressive.
Looking at the last year, ZENV shows a very strong growth in Revenue. The Revenue has grown by 24.00%.
ZENV shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.07% yearly.
EPS 1Y (TTM)29.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.92%
Revenue 1Y (TTM)24%
Revenue growth 3Y16.16%
Revenue growth 5Y22.07%
Sales Q2Q%28.81%

3.2 Future

The Earnings Per Share is expected to grow by 32.12% on average over the next years. This is a very strong growth
ZENV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.99% yearly.
EPS Next Y96.17%
EPS Next 2Y43.44%
EPS Next 3Y32.12%
EPS Next 5YN/A
Revenue Next Year-1.64%
Revenue Next 2Y1.05%
Revenue Next 3Y2.99%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ZENV Yearly Revenue VS EstimatesZENV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
ZENV Yearly EPS VS EstimatesZENV Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -1 -2 -3

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

ZENV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 50.56, the valuation of ZENV can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as ZENV.
ZENV's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 35.31.
Industry RankSector Rank
PE N/A
Fwd PE 50.56
ZENV Price Earnings VS Forward Price EarningsZENV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ZENV is valued cheaply inside the industry as 98.23% of the companies are valued more expensively.
ZENV's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ZENV is cheaper than 97.53% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.45
EV/EBITDA 4.23
ZENV Per share dataZENV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

ZENV's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ZENV's earnings are expected to grow with 32.12% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.44%
EPS Next 3Y32.12%

More info and screens

0

5. Dividend

5.1 Amount

ZENV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ZENVIA INC - A

NASDAQ:ZENV (8/15/2025, 11:45:07 AM)

After market: 1.7 +0.06 (+3.66%)

1.64

+0.01 (+0.61%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)07-02 2025-07-02/amc
Earnings (Next)09-05 2025-09-05
Inst Owners9.13%
Inst Owner Change-2.25%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap86.00M
Analysts43.33
Price Target1.53 (-6.71%)
Short Float %0.84%
Short Ratio1.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1332.15%
Min EPS beat(2)-2805.23%
Max EPS beat(2)140.93%
EPS beat(4)2
Avg EPS beat(4)-585.19%
Min EPS beat(4)-2805.23%
Max EPS beat(4)757.84%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)8.05%
Min Revenue beat(2)-9.77%
Max Revenue beat(2)25.87%
Revenue beat(4)3
Avg Revenue beat(4)7.38%
Min Revenue beat(4)-9.77%
Max Revenue beat(4)25.87%
Revenue beat(8)7
Avg Revenue beat(8)122.88%
Revenue beat(12)7
Avg Revenue beat(12)71.51%
Revenue beat(16)10
Avg Revenue beat(16)79.63%
PT rev (1m)-9.09%
PT rev (3m)-11.76%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-174.05%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.49%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 50.56
P/S 0.45
P/FCF 6.45
P/OCF 3.63
P/B 0.59
P/tB N/A
EV/EBITDA 4.23
EPS(TTM)-0.35
EYN/A
EPS(NY)0.03
Fwd EY1.98%
FCF(TTM)0.25
FCFY15.5%
OCF(TTM)0.45
OCFY27.58%
SpS3.68
BVpS2.77
TBVpS-1.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.42%
ROE -12.08%
ROCE 1.08%
ROIC 0.86%
ROICexc 0.94%
ROICexgc N/A
OM 1.03%
PM (TTM) N/A
GM 26.42%
FCFM 6.9%
ROA(3y)-8.63%
ROA(5y)-6.61%
ROE(3y)-17.47%
ROE(5y)-14.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5Y-49.64%
OM growth 3YN/A
OM growth 5Y-41.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.3%
GM growth 5Y3.13%
F-Score5
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 1.51
Debt/EBITDA 0.31
Cap/Depr 61.41%
Cap/Sales 5.38%
Interest Coverage 0.61
Cash Conversion 125.42%
Profit Quality N/A
Current Ratio 0.44
Quick Ratio 0.44
Altman-Z 0.43
F-Score5
WACC18.69%
ROIC/WACC0.05
Cap/Depr(3y)64.4%
Cap/Depr(5y)60.76%
Cap/Sales(3y)6.52%
Cap/Sales(5y)5.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.92%
EPS Next Y96.17%
EPS Next 2Y43.44%
EPS Next 3Y32.12%
EPS Next 5YN/A
Revenue 1Y (TTM)24%
Revenue growth 3Y16.16%
Revenue growth 5Y22.07%
Sales Q2Q%28.81%
Revenue Next Year-1.64%
Revenue Next 2Y1.05%
Revenue Next 3Y2.99%
Revenue Next 5YN/A
EBIT growth 1Y144.43%
EBIT growth 3YN/A
EBIT growth 5Y-28.23%
EBIT Next Year307.2%
EBIT Next 3Y76.71%
EBIT Next 5YN/A
FCF growth 1Y-58.13%
FCF growth 3YN/A
FCF growth 5Y23.72%
OCF growth 1Y-43.02%
OCF growth 3YN/A
OCF growth 5Y32.39%